DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
18.16
-0.25 (-1.36%)
May 13, 2025, 2:45 PM CST
SHA:603233 Market Cap
SHA:603233 has a market cap or net worth of 20.74 billion as of May 13, 2025. Its market cap has decreased by -15.54% in one year.
Market Cap
20.74B
Enterprise Value
22.11B
Revenue
26.70B
Ranking
n/a
PE Ratio
21.12
Stock Price
18.16
Market Cap Chart
Since July 31, 2017, SHA:603233's market cap has increased from 14.24B to 20.74B, an increase of 45.63%. That is a compound annual growth rate of 4.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 335.80B |
Shenzhen Mindray Bio-Medical Electronics | 270.90B |
WuXi AppTec | 168.36B |
Zhangzhou Pientzehuang Pharmaceutical., | 125.22B |
Aier Eye Hospital Group | 119.56B |
Sichuan Biokin Pharmaceutical | 112.28B |
Shanghai United Imaging Healthcare | 112.08B |
Yunnan Baiyao Group Co.,Ltd | 101.81B |